4.8 Article

Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL

期刊

SCIENCE
卷 321, 期 5889, 页码 686-691

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1157610

关键词

-

资金

  1. NCI NIH HHS [R01 CA042471-23, CA42471, R01 CA042471] Funding Source: Medline
  2. NHLBI NIH HHS [T32 HL066987] Funding Source: Medline
  3. NIAID NIH HHS [R01 AI044432, R21 AI071060-02, AI40127, R01 AI044432-10, R21 AI071060, R01 AI040127-18, R01 AI044432-09, R01 AI040127, R01 AI080875, R01 AI080875-01, R21 AI071060-01, AI44432, R01 AI040127-19, U19 AI070352] Funding Source: Medline

向作者/读者索取更多资源

The transition from naive to activated T cells is marked by alternative splicing of pre- mRNA encoding the transmembrane phosphatase CD45. Using a short hairpin RNA interference screen, we identified heterogeneous ribonucleoprotein L- like ( hnRNPLL) as a critical inducible regulator of CD45 alternative splicing. HnRNPLL was up- regulated in stimulated T cells, bound CD45 transcripts, and was both necessary and sufficient for CD45 alternative splicing. Depletion or overexpression of hnRNPLL in B and T cell lines and primary T cells resulted in reciprocal alteration of CD45RA and RO expression. Exon array analysis suggested that hnRNPLL acts as a global regulator of alternative splicing in activated T cells. Induction of hnRNPLL during hematopoietic cell activation and differentiation may allow cells to rapidly shift their transcriptomes to favor proliferation and inhibit cell death.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据